Rucaparib maintenance therapy for ovarian, fallopian tube or primary peritoneal cancer after frontline platinum-based chemotherapy

Rucaparib is currently in clinical development for the maintenance treatment of ovarian, fallopian tube, or primary peritoneal cancer, after front-line platinum-based chemotherapy. Epithelial ovarian cancers are the most common type of ovarian cancer. Primary peritoneal cancer and fallopian tube cancer are similar to epithelial ovarian cancer. All three types show signs of pain and swelling in the abdominal area. The optimal treatment strategy for women with newly diagnosed ovarian cancer has yet to be determined.